Exercise-induced Pulmonary Hypertension in Patients With Sickle-cell Anemia
NCT ID: NCT00948012
Last Updated: 2009-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
44 participants
OBSERVATIONAL
2006-06-30
2007-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Heart Disease in Sickle Cell Anemia
NCT00113152
Exploration of the Parameters Influencing the Effort Limitation of Patients Suffering From Homozygous Sickle Cell Anemia
NCT06743139
Study of Ventilatory Mechanics in Patients With Sickle Cell Anemia
NCT02565849
Pulmonary Hypertension, Hypoxia and Sickle Cell Disease
NCT00495638
Diastolic Dysfunction in Sickle Cell Disease During Vaso-occlusive Crisis
NCT01683968
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients without pulmonary hypertension
Patients with sickle cell with normal response of pulmonary artery pressure to exercise
No interventions assigned to this group
Exercise-induced pulmonary hypertension
Patients with sickle-cell anemia with exercise-induced pulmonary hypertension.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* preserved physical capacity
* steady state of the disease
Exclusion Criteria
* Recent sickling crisis(\<2 months)
* High Blood Pressure
* Atrial fibrillation
* Chronic obstructive pulmonary disease
* Last blood transfusion \> 3 months before
* Signs of congestive heart failure or significant valve disease
* Normal global and regional systolic function on echocardiography
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Federal University of São Paulo
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Orlando C Filho
Role: STUDY_CHAIR
Federal University of São Paulo
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HPSC01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.